Trailing-twelve-month (TTM) revenue is $3.77 Billion with a year-over-year growth of (4.99%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-20 |
| Q1 FY2026Period ended 2026-03-31 | $1,872,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $1,896,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $3,768,000,000 |
Current P/S: $8,762,899,345 market capitalization ÷ $3,768,000,000 TTM revenue = 2.33x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.90B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T21:10:55.329Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Corporate Segment | N/A | N/A | N/A | -$36M | $28M | N/A |
| Distribution Fees | $438M | $399M |
$3.77B
$3.77 Billion
(4.99%)
vs. $3.97B a year ago (TTM)
(4.91%)
5 Year compound annual growth rate
1 Year
(4.99%)
3 Year
(17.06%)
5 Year
(4.91%)
10 Year
(10.46%)
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.50B | ($554.00M) | (6.88%) |
| 2024 | $8.05B | +$702.00M | +9.55% |
| 2023 | $7.35B | +$1.42B | +23.91% |
| 2022 | $5.93B | +$1.70B | +40.19% |
| 2021 | $4.23B | ($3.42B) | (44.70%) |
| 2020 |
TTM Growth
(4.99%)
3-Year CAGR
(17.06%)
5-Year CAGR
(4.91%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| N/A |
| N/A |
| N/A |
| Employee Benefits | N/A | N/A | N/A | $2.5B | $2.7B | N/A |
|---|
| Health Solutions Segment | N/A | N/A | N/A | N/A | N/A | $3.6B |
|---|
| Investment Management | N/A | N/A | N/A | $745M | $924M | N/A |
|---|
| Investment Management Segment | N/A | N/A | N/A | N/A | N/A | $1.0B |
|---|
| Retirement | N/A | N/A | N/A | $993M | $1.0B | N/A |
|---|
| $7.65B |
| +$171.00M |
| +2.29% |
| 2019 | $7.48B | +$317.00M | +4.43% |
| 2018 | $7.16B | ($68.00M) | (0.94%) |
| 2017 | $7.23B | ($1.56B) | (17.74%) |
| 2016 | $8.79B | +$45.00M | +0.51% |
